Market Research Logo

EndoStim Inc - Product Pipeline Analysis, 2017 Update

Summary

EndoStim Inc (EndoStim) is a medical device company that offers therapeutic solutions. The company develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. It concentrates on the treatment of gastroesophageal reflux disease through electrical stimulation. EndoStim also conducts clinical research for various drugs. The company conducts research on common symptoms and causes of gastroesophageal reflux disease. It markets its products in domestic and international healthcare markets through its network of distributors. The company has presence in Europe, Asia, and Latin America. EndoStim is headquartered in Dallas, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company EndoStim Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


EndoStim Inc Company Overview
EndoStim Inc Company Snapshot
EndoStim Inc Pipeline Products and Ongoing Clinical Trials Overview
EndoStim Inc – Pipeline Analysis Overview
EndoStim Inc - Key Facts
EndoStim Inc - Major Products and Services
EndoStim Inc Pipeline Products by Development Stage
EndoStim Inc Ongoing Clinical Trials by Trial Status
EndoStim Inc Pipeline Products Overview
EndoStim LES Stimulation System
EndoStim LES Stimulation System Product Overview
EndoStim LES Stimulation System Clinical Trial
Implantable Device - Sexual Dysfunction
Implantable Device - Sexual Dysfunction Product Overview
Implantable Device - Urinary Incontinence
Implantable Device - Urinary Incontinence Product Overview
EndoStim Inc - Key Competitors
EndoStim Inc - Key Employees
EndoStim Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
EndoStim Inc, Recent Developments
Apr 19, 2017: First patients at Vanderbilt University Medical Center implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD)
Dec 20, 2016: First two patients at HonorHealth Research Institute implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD)
Dec 01, 2016: First two patients at SurgOne Foregut Institute implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD)
Nov 30, 2016: EndoStim Opens its New Corporate Headquarters in Dallas
Nov 03, 2016: First patient implanted in EndoStim's Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) clinical trial
Oct 28, 2016: New data on EndoStim therapy for the treatment of gastro-esophageal reflux disease presented at United European Gastroenterology Week 2016
May 31, 2016: New data on EndoStim therapy for the treatment of gastro-esophageal reflux disease presented at Digestive Disease Week 2016
May 17, 2016: EndoStim Names Rohan Hoare, Ph.D., as New President and CEO
Dec 02, 2015: EndoStim's Neurostimulation Therapy for Gastroesophageal Reflux Disease Approved in Brazil
Oct 20, 2015: EndoStim Receives CE Mark Approval For Full Body MRI Of Patients With Its LES Stimulation System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tabless
EndoStim Inc Pipeline Products and Ongoing Clinical Trials Overview
EndoStim Inc Pipeline Products by Equipment Type
EndoStim Inc Pipeline Products by Indication
EndoStim Inc Ongoing Clinical Trials by Trial Status
EndoStim Inc, Key Facts
EndoStim Inc, Major Products and Services
EndoStim Inc Number of Pipeline Products by Development Stage
EndoStim Inc Pipeline Products Summary by Development Stage
EndoStim Inc Ongoing Clinical Trials by Trial Status
EndoStim Inc Ongoing Clinical Trials Summary
EndoStim LES Stimulation System - Product Status
EndoStim LES Stimulation System - Product Description
EndoStim LES Stimulation System - A Multicenter, Randomized, Double-blind, Sham-controlled Clinical Investigation of the Endostim Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD)
EndoStim LES Stimulation System - An Investigation of Electrical Stimulation on Gastroesophageal Reflux Disease (GERD) in Patients after Sleeve Gastrectomy
EndoStim LES Stimulation System - An Investigation of the Effect of Long-term Electrical Stimulation on Lower Esophageal Sphincter (LES) Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD)
EndoStim LES Stimulation System - EndoStim Patient Registry-LES Stimulation System for the Treatment of GERD
EndoStim LES Stimulation System - Lost Patients – under-treated GERD Patients in Community Clinics in Germany
Implantable Device - Sexual Dysfunction - Product Status
Implantable Device - Sexual Dysfunction - Product Description
Implantable Device - Urinary Incontinence - Product Status
Implantable Device - Urinary Incontinence - Product Description
EndoStim Inc, Key Employees
EndoStim Inc, Other Locations
Glossary
List of Figures
EndoStim Inc Pipeline Products by Equipment Type
EndoStim Inc Pipeline Products by Development Stage
EndoStim Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report